Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study

Jiang, N; Li, MT; Zhang, HF; Duan, XW; Li, XF; Fang, YF; Li, HB; Yang, PT; Luo, H; Wang, YH; Peng, LY; Zhao, JL; Wu, CY; Wang, Q; Tian, XP; Zhao, Y; Zeng, XF

Li, MT; Zeng, XF (通讯作者)，Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing, Peoples R China.;Li, MT; Zeng, XF (通讯作者)，Minist Sci & Technol, Natl Clin Res Ctr Dermatol & Immunol Dis NCRC DID, Beijing, Peoples R China.;Li, MT; Zeng, XF (通讯作者)，State Key Lab Complex Severe & Rare Dis, Beijing, Peoples R China.;Li, MT; Zeng, XF (通讯作者)，Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China.

LUPUS SCIENCE & MEDICINE, 2022; 9 (1):

Abstract

Objective The effectiveness and safety of sirolimus for SLE treatment have been shown in some uncontrolled studies. However, a comparison of sirolimus......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索